Temocillin Pharmacokinetic in Hemodialysis

Mise à jour : Il y a 4 ans
Référence : NCT02285075

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The current study aimed to explore the pharmacokinetics of temocillin in patients treated with haemodialysis and to demonstrated whether or not the pharmacodynamics target of a time above a MIC of 16 mg/L of more than 40 and 60 % of the dosing interval could be obtained with a dosing schedule of 1 gram/24 hours, 2 gram/48 hours and 3 gram/72 hours, all of these doses given after haemodialysis sessions only.


Critère d'inclusion

  • Gram-Negative Bacterial Infections,Renal Failure Chronic Requiring Hemodialysis

Liens